204 related articles for article (PubMed ID: 36927871)
1. Gut microbiome signatures of Yorkshire Terrier enteropathy during disease and remission.
Doulidis PG; Galler AI; Hausmann B; Berry D; Rodríguez-Rojas A; Burgener IA
Sci Rep; 2023 Mar; 13(1):4337. PubMed ID: 36927871
[TBL] [Abstract][Full Text] [Related]
2. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
[TBL] [Abstract][Full Text] [Related]
3. Microbial dysbiosis and fecal metabolomic perturbations in Yorkshire Terriers with chronic enteropathy.
Galler AI; Suchodolski JS; Steiner JM; Sung CH; Hittmair KM; Richter B; Burgener IA
Sci Rep; 2022 Jul; 12(1):12977. PubMed ID: 35902689
[TBL] [Abstract][Full Text] [Related]
4. A Preliminary Metabolomic Study of Yorkshire Terrier Enteropathy.
Galler AI; Klavins K; Burgener IA
Metabolites; 2022 Mar; 12(3):. PubMed ID: 35323707
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Fecal and Mucosa-Associated Microbiota in Dogs with Chronic Inflammatory Enteropathy.
Díaz-Regañón D; García-Sancho M; Villaescusa A; Sainz Á; Agulla B; Reyes-Prieto M; Rodríguez-Bertos A; Rodríguez-Franco F
Animals (Basel); 2023 Jan; 13(3):. PubMed ID: 36766216
[TBL] [Abstract][Full Text] [Related]
6. The Microbiome in Patients With Inflammatory Diseases.
Somineni HK; Kugathasan S
Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
[TBL] [Abstract][Full Text] [Related]
7. Human Gut Microbiome Transplantation in Ileitis Prone Mice: A Tool for the Functional Characterization of the Microbiota in Inflammatory Bowel Disease Patients.
Basson AR; Gomez-Nguyen A; Menghini P; Buttó LF; Di Martino L; Aladyshkina N; Osme A; LaSalla A; Fischer D; Ezeji JC; Erkkila HL; Brennan CJ; Lam M; Rodriguez-Palacios A; Cominelli F
Inflamm Bowel Dis; 2020 Feb; 26(3):347-359. PubMed ID: 31750921
[TBL] [Abstract][Full Text] [Related]
8. Microbiota alterations in acute and chronic gastrointestinal inflammation of cats and dogs.
Honneffer JB; Minamoto Y; Suchodolski JS
World J Gastroenterol; 2014 Nov; 20(44):16489-97. PubMed ID: 25469017
[TBL] [Abstract][Full Text] [Related]
9. Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota.
Altomare A; Putignani L; Del Chierico F; Cocca S; Angeletti S; Ciccozzi M; Tripiciano C; Dalla Piccola B; Cicala M; Guarino MPL
Dig Liver Dis; 2019 May; 51(5):648-656. PubMed ID: 30573380
[TBL] [Abstract][Full Text] [Related]
10. Does canine inflammatory bowel disease influence gut microbial profile and host metabolism?
Xu J; Verbrugghe A; Lourenço M; Janssens GP; Liu DJ; Van de Wiele T; Eeckhaut V; Van Immerseel F; Van de Maele I; Niu Y; Bosch G; Junius G; Wuyts B; Hesta M
BMC Vet Res; 2016 Jun; 12(1):114. PubMed ID: 27306031
[TBL] [Abstract][Full Text] [Related]
11. The Gut Microbiome and Inflammatory Bowel Diseases.
Shan Y; Lee M; Chang EB
Annu Rev Med; 2022 Jan; 73():455-468. PubMed ID: 34555295
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota, inflammatory bowel disease and colorectal cancer.
Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
[TBL] [Abstract][Full Text] [Related]
14. Effects of the Dietary Protein and Carbohydrate Ratio on Gut Microbiomes in Dogs of Different Body Conditions.
Li Q; Lauber CL; Czarnecki-Maulden G; Pan Y; Hannah SS
mBio; 2017 Jan; 8(1):. PubMed ID: 28119466
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
Lopetuso LR; Petito V; Graziani C; Schiavoni E; Paroni Sterbini F; Poscia A; Gaetani E; Franceschi F; Cammarota G; Sanguinetti M; Masucci L; Scaldaferri F; Gasbarrini A
Dig Dis; 2018; 36(1):56-65. PubMed ID: 28683448
[TBL] [Abstract][Full Text] [Related]
16. Analysis and Comparison of Gut Microbiome in Young Detection Dogs.
Li Z; Sun Q; Li Y; Guan Z; Wei J; Li B; Liu K; Shao D; Mi R; Liu H; Qiu Y; Ma Z
Front Microbiol; 2022; 13():872230. PubMed ID: 35516435
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
Qiao YQ; Cai CW; Ran ZH
J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
[TBL] [Abstract][Full Text] [Related]
18. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
[TBL] [Abstract][Full Text] [Related]
20. Potential of Gut Microbe-Derived Extracellular Vesicles to Differentiate Inflammatory Bowel Disease Patients from Healthy Controls.
Heo M; Park YS; Yoon H; Kim NE; Kim K; Shin CM; Kim N; Lee DH
Gut Liver; 2023 Jan; 17(1):108-118. PubMed ID: 36424722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
